Literature DB >> 16629623

Overcoming inhibition in the damaged spinal cord.

James W Fawcett1.   

Abstract

Inhibition by several inhibitory molecules on oligodendrocytes, and by chondroitin sulphate proteoglycans and semaphorins in the glial scar discourages regeneration of axons in the injured spinal cord. This inhibition is compounded by the poor regenerative ability of most central nervous system (CNS) axons. Treatments that block some of these inhibitory mechanisms promote regeneration in animal models of cord injury. Plasticity is also reduced by some of the inhibitory molecules, and some of the treatments that promote regeneration also promote plasticity. This is probably a more achievable therapeutic target than axon regeneration, and an effective treatment would be of assistance to the majority of patients with partial cord injuries.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16629623     DOI: 10.1089/neu.2006.23.371

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  87 in total

1.  Permanent reorganization of Ia afferent synapses on motoneurons after peripheral nerve injuries.

Authors:  Francisco J Alvarez; Katie L Bullinger; Haley E Titus; Paul Nardelli; Timothy C Cope
Journal:  Ann N Y Acad Sci       Date:  2010-06       Impact factor: 5.691

2.  Sialidase enhances recovery from spinal cord contusion injury.

Authors:  Andrea Mountney; Matthew R Zahner; Ileana Lorenzini; Martin Oudega; Lawrence P Schramm; Ronald L Schnaar
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

3.  Expression of a dominant-negative Rho-kinase promotes neurite outgrowth in a microenvironment mimicking injured central nervous system.

Authors:  Ping Yang; Hui-zhong Wen; Jin-hai Zhang
Journal:  Acta Pharmacol Sin       Date:  2010-04-12       Impact factor: 6.150

4.  Description of sensory preservation in children and adolescents with incomplete spinal cord injury.

Authors:  Randal R Betz; Ross S Chafetz; Lawrence C Vogel; Amer F Samdani; Mary Jane Mulcahey
Journal:  J Spinal Cord Med       Date:  2011       Impact factor: 1.985

5.  Aspiration of a cervical spinal contusion injury in preparation for delayed peripheral nerve grafting does not impair forelimb behavior or axon regeneration.

Authors:  Harra R Sandrow; Jed S Shumsky; Arthi Amin; John D Houle
Journal:  Exp Neurol       Date:  2007-12-15       Impact factor: 5.330

6.  Intraspinal microinjection of chondroitinase ABC following injury promotes axonal regeneration out of a peripheral nerve graft bridge.

Authors:  Veronica J Tom; John D Houlé
Journal:  Exp Neurol       Date:  2008-02-14       Impact factor: 5.330

7.  Multiple channel bridges for spinal cord injury: cellular characterization of host response.

Authors:  Yang Yang; Laura De Laporte; Marina L Zelivyanskaya; Kevin J Whittlesey; Aileen J Anderson; Brian J Cummings; Lonnie D Shea
Journal:  Tissue Eng Part A       Date:  2009-11       Impact factor: 3.845

8.  Matrix metalloproteinase-14 both sheds cell surface neuronal glial antigen 2 (NG2) proteoglycan on macrophages and governs the response to peripheral nerve injury.

Authors:  Tasuku Nishihara; Albert G Remacle; Mila Angert; Igor Shubayev; Sergey A Shiryaev; Huaqing Liu; Jennifer Dolkas; Andrei V Chernov; Alex Y Strongin; Veronica I Shubayev
Journal:  J Biol Chem       Date:  2014-12-08       Impact factor: 5.157

9.  Liquid chromatography-mass spectrometry to study chondroitin lyase action pattern.

Authors:  Zhenqing Zhang; Youmie Park; Melissa M Kemp; Wenjing Zhao; A-Rang Im; David Shaya; Miroslaw Cygler; Yeong Shik Kim; Robert J Linhardt
Journal:  Anal Biochem       Date:  2008-10-17       Impact factor: 3.365

10.  Intravenous Infusion of Mesenchymal Stem Cells Alters Motor Cortex Gene Expression in a Rat Model of Acute Spinal Cord Injury.

Authors:  Tsutomu Oshigiri; Toru Sasaki; Masanori Sasaki; Yuko Kataoka-Sasaki; Masahito Nakazaki; Shinichi Oka; Tomonori Morita; Ryosuke Hirota; Mitsunori Yoshimoto; Toshihiko Yamashita; Kazue Hashimoto-Torii; Osamu Honmou
Journal:  J Neurotrauma       Date:  2018-08-10       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.